Health authorities in South Africa announced Tuesday they were putting a pause on the single-shot Johnson & Johnson COVID-19 vaccine after six recipients, out of nearly 7 million total in the US, experienced rare blood clots. Host Carol Hills speaks with Mosa Moshabela, professor of public health at the University of KwaZulu-Natal, from Durban.